NZ Rare 9 Graff.png (43.8 kB)

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

Download (43.8 kB)
figure
posted on 28.02.2018 by Gavin R. Graff, John McNamara, James Royall, Steven Caras, Kristin Forssmann

The full text of this article can be found here:

https://link.springer.com/article/10.2165/11533390-000000000-00000


Funding

Solvay Pharmaceuticals, Inc.

History

Licence

Exports

Logo branding

Licence

Exports